ORBIMED ADVISORS LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$8.0B
Holdings
141
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (141 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | OTICEUROTONOMY INC | 3,250,000 | $13.2B | 165.44% | |
| 102 | CMPSCOMPASS PATHWAYS PLC | 350,000 | $12.2B | 153.53% | |
| 103 | GILDGILEAD SCIENCES INC | 192,200 | $12.1B | 152.65% | |
| 104 | BLUBELLUS HEALTH INC NEW | 5,137,216 | $11.7B | 147.41% | |
| 105 | ANNXANNEXON INC | 379,947 | $11.5B | 144.37% | |
| 106 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $11.5B | 143.95% | |
| 107 | BDQMALBIREO PHARMA INC | 328,385 | $11.0B | 137.73% | |
| 108 | INZYINOZYME PHARMA INC | 400,400 | $10.5B | 132.31% | |
| 109 | NRIXNURIX THERAPEUTICS INC | 300,000 | $10.5B | 131.63% | |
| 110 | —AVROBIO INC | 793,712 | $10.3B | 129.89% | |
| 111 | TCE2CELLDEX THERAPEUTICS INC NEW | 625,000 | $9.3B | 116.50% | |
| 112 | EPIEURESSA PHARMA INC | 1,177,483 | $8.1B | 102.12% | |
| 113 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $7.8B | 97.92% | |
| 114 | XTNTXTANT MED HLDGS INC | 9,248,678 | $7.6B | 95.75% | |
| 115 | TARAPROTARA THERAPEUTICS INC | 450,000 | $7.6B | 95.20% | |
| 116 | ASNSUSDX4 PHARMACEUTICALS INC | 1,086,493 | $7.4B | 92.46% | |
| 117 | —STRONGBRIDGE BIOPHARMA PLC | 3,489,369 | $7.3B | 92.10% | |
| 118 | —AKOUOS INC | 315,000 | $7.2B | 90.55% | |
| 119 | DYNDYNE THERAPEUTICS INC | 350,000 | $7.1B | 88.82% | |
| 120 | HCATHEALTH CATALYST INC | 179,598 | $6.6B | 82.61% | |
| 121 | OMGBPOUTSET MED INC | 125,000 | $6.3B | 78.56% | |
| 122 | —MYOVANT SCIENCES LTD | 414,500 | $5.8B | 73.20% | Call |
| 123 | RCKTROCKET PHARMACEUTICALS INC | 253,108 | $5.8B | 72.72% | |
| 124 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $5.5B | 69.13% | |
| 125 | —APTOSE BIOSCIENCES INC | 897,541 | $5.4B | 67.68% | |
| 126 | SELBUSDSELECTA BIOSCIENCES INC | 2,093,869 | $5.2B | 65.27% | |
| 127 | ARNAEURARENA PHARMACEUTICALS INC | 66,700 | $5.0B | 62.69% | |
| 128 | ACADACADIA PHARMACEUTICALS INC | 107,000 | $4.4B | 55.48% | |
| 129 | —SYNLOGIC INC | 2,029,996 | $4.1B | 51.54% | |
| 130 | KYMRKYMERA THERAPEUTICS INC | 100,000 | $3.2B | 40.61% | |
| 131 | —OBSEVA SA | 1,303,000 | $3.2B | 40.61% | |
| 132 | IFRXINFLARX NV | 678,525 | $2.9B | 36.34% | |
| 133 | MISTMILESTONE PHARMACEUTICALS IN | 385,791 | $2.8B | 35.49% | |
| 134 | ANABANAPTYSBIO INC | 180,442 | $2.7B | 33.46% | |
| 135 | RNAAVIDITY BIOSCIENCES INC | 63,860 | $1.8B | 22.60% | |
| 136 | —KITOV PHARMA LTD | 346,197 | $1.5B | 19.19% | |
| 137 | —CURIS INC | 1,241,494 | $1.5B | 18.26% | |
| 138 | —NABRIVA THERAPEUTICS PLC | 2,644,600 | $1.4B | 17.72% | |
| 139 | BMY-RBRISTOL-MYERS SQUIBB CO | 400,000 | $900.0M | 11.31% | |
| 140 | —CALLIDITAS THERAPEUTICS AB | 17,696 | $425.0M | 5.34% | |
| 141 | —BIOLINERX LTD | 69,240 | $114.0M | 1.43% |
PreviousPage 2 of 2